4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine has been researched along with ketotifen in 1 studies
Studies (4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine) | Trials (4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine) | Recent Studies (post-2010) (4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine) | Studies (ketotifen) | Trials (ketotifen) | Recent Studies (post-2010) (ketotifen) |
---|---|---|---|---|---|
51 | 1 | 8 | 1,212 | 275 | 151 |
Protein | Taxonomy | 4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine (IC50) | ketotifen (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.16 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.838 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.009 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.374 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.187 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 1.112 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.71 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.537 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 2.209 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.872 | |
Histamine H2 receptor | Homo sapiens (human) | 4.129 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.727 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.031 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.16 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 2.537 | |
Histamine H1 receptor | Homo sapiens (human) | 0.0011 | |
D(3) dopamine receptor | Homo sapiens (human) | 1.963 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.046 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.141 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Komatsu, H; Tomomatsu, N; Yamaguchi, S | 1 |
1 other study(ies) available for 4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine and ketotifen
Article | Year |
---|---|
Effect of Y-24180, a receptor antagonist to platelet-activating factor (PAF), on allergic cutaneous reactions in actively sensitized mice.
Topics: Administration, Oral; Administration, Topical; Allergens; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Arylsulfonates; Azepines; Dermatitis, Allergic Contact; Ear; Eosinophils; Histamine H1 Antagonists; Hydrocortisone; Immunoglobulin E; Immunoglobulin G; Ketotifen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Ovalbumin; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Sulfonium Compounds; Time Factors; Triazoles | 2000 |